Clinical Trial Update: S0916, MLN1202 in Treating Patients With Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update for S0916 and MLN1202 in patients with bone metastases has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Bone Metastases
• Cancer

Drugs mentioned

• MLN1202
• S0916

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED | Results posted: 2014-05-28